Clolar Confirmatory Study Should Be In Early-Relapse Patients, Cmte. Says
Executive Summary
Genzyme's confirmatory study for Clolar should be conducted in an early-relapse leukemia pediatric population, members of the Oncologic Drugs Advisory Committee Pediatric Subcommittee said Oct. 20